Smith & Nephew

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Smith & Nephew and other ETFs, options, and stocks.

About SNN

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. 

CEO
Deepak S Nath
CEODeepak S Nath
Employees
18,456
Employees18,456
Headquarters
Watford, Herefordshire
HeadquartersWatford, Herefordshire
Founded
1856
Founded1856
Employees
18,456
Employees18,456

SNN Key Statistics

Market cap
13.64B
Market cap13.64B
Price-Earnings ratio
28.86
Price-Earnings ratio28.86
Dividend yield
2.24%
Dividend yield2.24%
Average volume
552.51K
Average volume552.51K
High today
$32.56
High today$32.56
Low today
$32.06
Low today$32.06
Open price
$32.36
Open price$32.36
Volume
141.31K
Volume141.31K
52 Week high
$38.79
52 Week high$38.79
52 Week low
$23.69
52 Week low$23.69

Stock Snapshot

Smith & Nephew(SNN) stock is priced at $32.19, giving the company a market capitalization of 13.64B. It carries a P/E multiple of 28.86 and pays a dividend yield of 2.2%.

As of 2025-12-15, Smith & Nephew(SNN) stock has fluctuated between $32.06 and $32.56. The current price stands at $32.19, placing the stock +0.4% above today's low and -1.2% off the high.

Smith & Nephew(SNN) shares are trading with a volume of 141.31K, against a daily average of 552.51K.

During the past year, Smith & Nephew(SNN) stock moved between $23.69 at its lowest and $38.79 at its peak.

During the past year, Smith & Nephew(SNN) stock moved between $23.69 at its lowest and $38.79 at its peak.

SNN News

TipRanks 6h
Smith & Nephew downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital downgraded Smith & Nephew to Sector Perform from Outperform with a price target of 1,350 GBp, down from 1,700 GBp. The firm sees “material risk” of...

TipRanks 3d
Smith & Nephew Snats: Hold Rating Amid Strategic Ambitions and Execution Risks

Caitlin Roberts, an analyst from Canaccord Genuity, maintained the Hold rating on Smith & Nephew Snats. The associated price target is $34.00. Claim 50% Off Tip...

TipRanks 6d
Smith & Nephew: Poised for Growth with Strategic Investments and Strong Product Pipeline

Smith & Nephew, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Julien Ouaddour from Bank of America Securities reiterated...

Analyst ratings

63%

of 19 ratings
Buy
36.8%
Hold
63.2%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.